Literature DB >> 1308059

ABO blood groups system in laryngeal cancer patients and after survival of 3 and 5 years.

A Konieczna1, G Turowski.   

Abstract

The analyzed material comprised 200 patients with cancer of the larynx with various locations of the tumour and patients surviving 3 and 5 years after operation. The frequency of ABO blood groups was analysed separately in cases of epiglottis cancer (n = 153) and glottis cancer (n = 37). The frequency of A1, A2, B, A1B, A2B, O blood groups was compared with that in 22,422 healthy individuals living in South Poland. The A2B blood group was significantly more frequent in patients with epiglottis cancer and in those with laryngeal cancer. The difference was not significant after survival of 3 and 5 years.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1308059

Source DB:  PubMed          Journal:  Mater Med Pol        ISSN: 0025-5246


  2 in total

1.  ABO blood group is a predictor of survival in patients with laryngeal cancer.

Authors:  Ting Jin; Pei-Jing Li; Xiao-Zhong Chen; Wei-Han Hu
Journal:  Chin J Cancer       Date:  2016-10-13

2.  Blood Group Type Association with Head and Neck Cancer.

Authors:  Gaube Alexandra; Michire Alexandru; Calangiu Filip Stefan; Draghia Petruta-Maria; Burlacu Mihnea Gabriel; Georgescu Dragos-Eugen; Georgescu Mihai Teodor
Journal:  Hematol Rep       Date:  2022-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.